ERNA

Conviction 31HealthcareScan · Tue, Sep 8, 2026

Bearish marubozu

ERNA$4.12-4.41%

ResistanceSupportVol 14

Vol MA14 31.76K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Ernexa Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.ernexatx.com ↗

Price4.12

Change-4.41%

Gap-1.16%

Rel volume0.18×

Avg volume32.09K

Avg $ vol145.96K

SMA 204.50

SMA 504.88

SMA 2003.22

Price vs 50-15.59%

Price vs 200+27.88%

MA stackmixed

50/200 cross—

Supertrenddown · 5.09

RSI (14)41

MACD hist-0.01

MACD crossbear · 0d

Stoch %K / %D0 / 17

ADX (14)16

+DI / −DI21 / 19

RSI divergence—

MACD divergence—

ATR %+10.96%

ADR %8.60%

52w high13.63

52w low0.1476

From 52w high-69.77%

Above 52w low+2691.33%

New 52w highNo

SqueezeOn · 6d

Bollinger width23.43%

%B0.14

Donchian pos6.71%

Donchian high5.51

Donchian low4.02

AVWAP (52w high)9.34

vs AVWAP high-55.88%

AVWAP (52w low)7.43

vs AVWAP low-44.52%

OBV trendDown

Chaikin MF (20)-0.37

Today vs 20d0.18×

Avg vol (14d)31.76K

Avg vol (20d)32.09K

Avg $ vol (20d)145.96K

Market cap6.73M

RS 3m (vs SPY)-49.80%

RS 6m (vs SPY)+1397.73%

RS line new highNo

Trend template5/8

Technical rank61.3

1 week-9.85%

1 month-2.14%

3 months-44.25%

6 months+1355.83%

1 year+228.29%

YTD+255.17%

P/E-0.48

P/B2.10

P/S1.16

P/FCF-0.95

EPS-2.24

Div yield—

ROE-440.13%

ROA-223.02%

Debt/Eq0.64

Current2.01

EV/EBITDA-0.48

Gross margin8.38%

Net margin-242.83%

Rev growth-70.72%

EPS growth68.38%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value4.44M

Revenue1.48M

Net income-4.01M

Gross profit547K

Free cash flow-7.05M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.17M

Employees5

ListedFri, Mar 26, 2021

Free float13.66M

Float %46.9%

Short interest24.66K

Days to cover0.5d

Short volume13.5%

Squeeze score3 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$3.40 vs −$3.30

Last surprise-3.0% miss

Setup gradeD

Conviction31 / 100

Pattern quality—

Tech rank61.3 / 100

Group rank96 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ERNA

All disclosures →

No recent disclosed trades by Congress in ERNA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ERNA · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Bristol James Arthur Director · Stock Option (Right to buy) · 2026-08-31	Grant	8.32K	—	2026-08-31	2026-09-01
Bristol James Arthur Director · Stock Option (Right to buy) · 2026-08-31	Grant	5.08K	—	2026-08-31	2026-09-01

SEC filings

EDGAR filings in ERNA · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.